학술논문
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected.
Document Type
Article
Author
Kappel-Latif, Sonja; Zacherl, Johannes; Hejna, Michael; Westerhoff, Maria; Tamandl, Dietmar; Ba-Ssalamah, Ahmed; Mittlböck, Martina; Wolf, Brigitte; Wrba, Friedrich; Kührer, Irene; Pluschnig, Ursula; Schoppmann, Sebastian F.; Függer, Reinhold; Zwrtek, Ronald; Glaser, Karl; Karner, Josef; Längle, Friedrich; Wenzl, Etienne; Roka, Rudolf; Öfner, Dietmar
Source
Subject
Language
ISSN
1682-8631